Your browser doesn't support javascript.
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy.
Dahiya, Saurabh; Luetkens, Tim; Lutfi, Forat; Avila, Stephanie; Iraguha, Thierry; Margiotta, Philip; Hankey, Kim G; Lesho, Patricia; Law, Jennie Y; Lee, Seung T; Baddley, John; Kocoglu, Mehmet; Yared, Jean A; Hardy, Nancy M; Rapoport, Aaron P; Atanackovic, Djordje.
  • Dahiya S; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Luetkens T; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Lutfi F; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Avila S; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Iraguha T; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Margiotta P; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Hankey KG; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Lesho P; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Law JY; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Lee ST; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Baddley J; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Kocoglu M; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD.
  • Yared JA; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Hardy NM; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Rapoport AP; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
  • Atanackovic D; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
Blood Adv ; 6(2): 686-689, 2022 01 25.
Article in English | MEDLINE | ID: covidwho-1649608
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Blood Adv Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Blood Adv Year: 2022 Document Type: Article